Pathway Device Wins EU Approval
Luke Timmerman12/14/09
Pathway Medical Technologies, the Kirkland, WA-based developer of a medical device to clear out blockages in leg arteries, said today it has received regulatory clearance to sell the product in Europe. The company is now developing plans to sell the Jetstream G2 NXT for peripheral artery disease in all European Union countries. The product first won FDA approval in July 2008.
Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.
